Mesoblast Ltd. (MESO)
11.64
-0.27
(-2.27%)
USD |
NASDAQ |
Nov 18, 16:00
11.67
+0.03
(+0.26%)
After-Hours: 20:00
Mesoblast Enterprise Value : 1.554B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 1.554B |
| November 17, 2026 | 1.590B |
| November 16, 2026 | 1.660B |
| November 13, 2026 | 1.766B |
| November 12, 2026 | 1.744B |
| November 11, 2026 | 1.815B |
| November 10, 2026 | 1.859B |
| November 09, 2026 | 1.918B |
| November 06, 2026 | 1.896B |
| November 05, 2026 | 1.873B |
| November 04, 2026 | 1.898B |
| November 03, 2026 | 1.960B |
| November 02, 2026 | 1.931B |
| October 30, 2026 | 2.011B |
| October 29, 2026 | 2.077B |
| October 28, 2026 | 1.781B |
| October 27, 2026 | 1.754B |
| October 26, 2026 | 1.652B |
| October 23, 2026 | 1.637B |
| October 22, 2026 | 1.672B |
| October 21, 2026 | 1.709B |
| October 20, 2026 | 1.654B |
| October 19, 2026 | 1.595B |
| October 16, 2026 | 1.767B |
| October 15, 2026 | 1.854B |
| Date | Value |
|---|---|
| October 14, 2026 | 1.833B |
| October 13, 2026 | 1.847B |
| October 12, 2026 | 1.896B |
| October 09, 2026 | 1.898B |
| October 08, 2026 | 1.828B |
| October 07, 2026 | 1.853B |
| October 06, 2026 | 1.810B |
| October 05, 2026 | 1.889B |
| October 02, 2026 | 1.871B |
| October 01, 2026 | 1.902B |
| September 30, 2026 | 1.945B |
| September 29, 2026 | 1.973B |
| September 28, 2026 | 1.925B |
| September 25, 2026 | 2.006B |
| September 24, 2026 | 2.052B |
| September 23, 2026 | 2.028B |
| September 22, 2026 | 2.109B |
| September 21, 2026 | 2.052B |
| September 18, 2026 | 2.007B |
| September 17, 2026 | 1.973B |
| September 16, 2026 | 1.914B |
| September 15, 2026 | 1.956B |
| September 14, 2026 | 1.993B |
| September 11, 2026 | 2.052B |
| September 10, 2026 | 2.055B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Telix Pharmaceuticals Ltd. | 2.977B |
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | 1.880M |
Enterprise Value Related Metrics
| Earnings Yield | -3.83% |
| Normalized Earnings Yield | -4.447 |